Cancer can cause kidney stones, both directly and through the side effects of cancer treatment. Some tumors raise blood calcium or uric acid levels high enough to crystallize minerals in the kidneys, while chemotherapy and radiation introduce their own stone-forming risks. The relationship runs in several directions at once, and the specific pathway depends on the type of cancer, the treatment used, and the patient’s existing health profile.
How Cancer Itself Triggers Stone Formation
The most straightforward way a malignancy produces kidney stones is by disrupting the body’s calcium balance. Many cancers, especially those that spread to bone, cause the skeleton to release excess calcium into the bloodstream. Squamous cell cancers of the lung, head, and neck can also secrete a protein that mimics parathyroid hormone, tricking the body into pulling calcium from bone and reabsorbing it from the kidneys. The result is hypercalcemia, a condition where so much calcium circulates in the blood that the kidneys cannot handle the load. When calcium concentration in the urine climbs high enough, it binds with oxalate or phosphate and forms stones. Although kidney stone formation from hypercalcemic states is uncommon relative to the total number of stone cases, recognizing the connection matters because the stones may be the first clue that something else is wrong.1PubMed Central. Hypercalcemic States associated with nephrolithiasis
A second cancer-driven pathway involves uric acid. Blood cancers with high cell turnover, such as aggressive lymphomas and certain leukemias, can flood the bloodstream with purines released from dying tumor cells. The body converts purines into uric acid, and when uric acid levels spike, the kidneys struggle to flush it all out. In acidic urine, uric acid crystallizes easily and can form stones or even sludge that blocks the urinary tract. This process sometimes happens spontaneously, before any treatment begins, in patients with rapidly growing tumors.2Childhood Kidney Diseases. Spontaneous Tumor Lysis Syndrome Presenting Acute Kidney Injury with Extreme Hyperuricemia and Urinary Stone: A Rare Case of Spontaneous Tumor Lysis Syndrome
Parathyroid Carcinoma as a Special Case
Parathyroid carcinoma is rare, but it occupies a unique spot in the cancer-and-stones story. The parathyroid glands regulate how much calcium stays in your blood. When one of those glands becomes cancerous, it can churn out parathyroid hormone relentlessly, keeping calcium levels dangerously elevated for months or years. Unlike the milder calcium bumps seen with benign parathyroid adenomas, parathyroid carcinoma tends to produce severe hypercalcemia. Patients often present with kidney stones, bone pain, and bone lesions called brown tumors, sometimes all at once.3Current Problems in Cancer: Case Reports. Challenges in managing extensive brown tumors and renal stones in a young man with parathyroid carcinoma and single kidney: Case report
What makes parathyroid carcinoma tricky is that the stones may recur until the underlying cancer is controlled. Surgery to remove the cancerous gland is the primary treatment, but if the cancer has spread or if it recurs, calcium levels climb again. In someone who keeps forming calcium-based stones despite standard prevention measures, a thorough workup of parathyroid function is worth pursuing, especially if blood calcium is persistently high.
Tumor Lysis Syndrome and Its Complications
Tumor lysis syndrome is the most common metabolic emergency in patients with blood cancers. It happens when large numbers of cancer cells die rapidly, typically after the start of chemotherapy, and dump their internal contents into the bloodstream. The hallmark abnormalities are a surge in uric acid, potassium, and phosphorus, alongside a drop in calcium.2Childhood Kidney Diseases. Spontaneous Tumor Lysis Syndrome Presenting Acute Kidney Injury with Extreme Hyperuricemia and Urinary Stone: A Rare Case of Spontaneous Tumor Lysis Syndrome The uric acid spike is the piece most relevant to stones. When uric acid overwhelms the kidneys, crystals can precipitate in the renal tubules or collect into frank stones that obstruct urine flow.
To prevent this, oncology teams often prescribe drugs that block uric acid production before chemotherapy begins. One common class of preventive medication works by inhibiting the enzyme xanthine oxidase, which converts purines into uric acid. The catch is that blocking this enzyme can cause a buildup of xanthine, a precursor compound. In patients with very rapid tumor breakdown, xanthine itself can crystallize in the urinary tract. Case reports have documented yellowish and pinkish xanthine crystal deposits forming in urinary catheters and collection bags during aggressive treatment for blood cancers.4PubMed Central. Urine Xanthine Crystals in Hematologic Malignancies with Tumor Lysis Syndrome So even the treatment designed to prevent uric acid stones can, in extreme circumstances, create a different crystal problem.
Chemotherapy and Stone Risk Beyond Tumor Lysis
Kidney stones in cancer patients are not limited to the dramatic scenario of tumor lysis syndrome. A study of patients with lymphoproliferative and myeloproliferative disorders found that among those who developed stones, roughly three-quarters had lymphoproliferative conditions and about a quarter had myeloproliferative conditions. Only a quarter of the stone formers were taking allopurinol, a medication meant to keep uric acid in check. In that analysis, higher uric acid, higher calcium, and higher potassium levels were all more common in patients who formed stones than in those who did not. Diabetes and high blood pressure were also more frequent in stone formers.5PubMed. What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?
This last finding is worth pausing on. Cancer patients do not exist in a metabolic vacuum. Many of them already have conditions like diabetes and obesity that independently raise stone risk. Chemotherapy can worsen dehydration, alter kidney function, and shift the chemical composition of urine, all of which compound whatever baseline risk a patient carried before diagnosis. The interplay between the cancer itself, the treatment, and pre-existing metabolic conditions makes it difficult to pin every stone on a single cause. In the study above, diabetes, elevated uric acid, and elevated calcium were the strongest independent predictors of stone formation in a multivariate analysis.5PubMed. What is the incidence of kidney stones after chemotherapy in patients with lymphoproliferative or myeloproliferative disorders?
Radiation Therapy and Ureteral Damage
Pelvic radiation, used to treat cancers of the cervix, prostate, rectum, and other gastrointestinal organs, can damage the ureters, the narrow tubes that carry urine from each kidney to the bladder. Radiation injures the small blood vessels feeding the ureteral wall, leading to reduced blood flow, scar tissue buildup, and eventual narrowing of the tube.6PubMed Central. Management of Ureteral Stricture Disease After Radiation Therapy for Pelvic Malignancies: A Retrospective, Multi-Institutional Analysis This narrowing, called a stricture, is a recognized complication of pelvic radiation. When urine cannot drain freely past a stricture, it backs up into the kidney, and that stagnant urine becomes a breeding ground for crystals. The result can be kidney stone formation, infection, or progressive kidney damage.7Journal of Endourology and Minimaly Invasive Surgery. Overview of current treatment of radiation-induced ureteral strictures in the pelvic region
Radiation-induced strictures are considered rare, but because pelvic radiation is so widely used, a meaningful number of patients face the problem. The onset is often delayed by months or years after the radiation course ends, which means stones that appear long after treatment may still trace back to radiation damage. If you have undergone pelvic radiation and later develop flank pain or urinary symptoms, your medical team should consider imaging to check for ureteral narrowing alongside the usual stone workup.
Shared Risk Factors Between Stones and Urinary Tract Cancers
An entirely separate thread in the research examines whether kidney stones and certain cancers share common roots. Epidemiological studies have found overlapping risk factors for kidney stone disease and cancers of the upper urinary tract and bladder, including smoking, alcohol consumption, diet, and male sex.8PubMed Central. Understanding the link between kidney stones and cancers of the upper urinary tract and bladder This does not mean that kidney stones cause those cancers, or vice versa. It means that the same lifestyle and metabolic factors that make someone more prone to forming stones also appear to raise the odds of developing urinary tract malignancies.
One proposed explanation centers on chronic inflammation. A stone sitting in the kidney or ureter irritates the lining of the urinary tract, and prolonged irritation promotes cell turnover and DNA damage. Over many years, that low-grade inflammation could theoretically contribute to malignant transformation. The evidence is mostly observational, and it is hard to separate the effect of the stone itself from the effect of whatever metabolic environment caused the stone in the first place. Still, the association is consistent enough that researchers treat kidney stone patients who develop blood in the urine with appropriate suspicion, ruling out malignancy alongside the expected stone-related causes.
When Stones Complicate Cancer Treatment
The relationship is not just about cancer causing stones. Kidney stones can also get in the way of cancer treatment. A stone that blocks the ureter creates back pressure on the kidney, which can impair kidney function. If a patient needs nephrotoxic chemotherapy, reduced kidney function may force dose adjustments or treatment delays. From a clinical perspective, kidney stone disease can become a barrier to oncologic care because of the renal obstruction it causes.8PubMed Central. Understanding the link between kidney stones and cancers of the upper urinary tract and bladder
Cancer patients who develop obstruction often need a procedure to restore urine drainage, such as the placement of a ureteral stent or a percutaneous nephrostomy tube, a catheter that drains urine directly from the kidney through the back. These drainage devices carry their own risks. One study of cancer patients with nephrostomy catheters found that those with kidney stones were significantly more likely to develop recurrent urinary tract infections compared to those without stones.9PubMed Central. Evaluation of risk factors, causative pathogens, and treatment in recurrent percutaneous nephrostomy catheter-related urinary tract infections in cancer patients Recurrent infections on top of ongoing cancer treatment add another layer of complexity, potentially interrupting or delaying therapy further.
Imaging That Serves Double Duty
One silver lining in the overlap between cancer and kidney stones is that modern imaging can address both issues simultaneously. CT scans are the standard tool for diagnosing kidney stones and are also widely used in cancer staging and surveillance. Dual-energy CT, a newer technique, can go further: it helps characterize the chemical composition of a kidney stone, distinguish a simple fluid-filled kidney cyst from a solid tumor, and evaluate adrenal and pancreatic masses, all in a single scan.10PubMed. Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? For cancer patients who are already undergoing frequent imaging, this means a stone can be caught and characterized without adding extra tests.
Knowing the composition of a stone matters for treatment. Uric acid stones, the type most associated with blood cancers and tumor lysis syndrome, can sometimes be dissolved with medications that raise urine pH. Calcium-based stones, more typical of hyperparathyroidism and bone metastases, usually require procedural intervention if they do not pass on their own. Identifying the stone type early helps guide management and avoids unnecessary procedures.
Vitamin C Supplements and an Overlooked Risk
Cancer patients sometimes take high-dose vitamin C supplements in the belief that they support immune function during treatment. The evidence on whether this helps the cancer fight is a separate and contentious topic, but the connection to kidney stones is more straightforward. A large study found that men who took supplemental vitamin C at doses of 1,000 milligrams per day or more had a roughly 19% higher risk of developing kidney stones compared to non-users. The association followed a dose-response pattern, with risk climbing as intake increased. Women did not show the same relationship, and dietary vitamin C from food was not linked to stones in either sex.11PubMed Central. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones
The mechanism is thought to involve oxalate. The body converts a portion of vitamin C into oxalate, which is one of the main building blocks of the most common type of kidney stone. For a cancer patient who already faces elevated stone risk from hypercalcemia, chemotherapy-driven dehydration, or uric acid surges, adding a high-dose vitamin C supplement stacks another risk factor on top. This does not mean all vitamin C is dangerous, but if you are being treated for cancer and considering supplements, the kidney stone angle is worth discussing with your oncology team, especially if you are male.
Practical Steps for Cancer Patients at Risk
Staying well hydrated is the single most effective way to reduce stone risk in any population, and it is particularly relevant during cancer treatment, when nausea, vomiting, and reduced oral intake make dehydration common. Aiming for enough fluid to keep urine pale yellow is a simple target. For patients on chemotherapy regimens known to cause high uric acid levels, oncology teams typically prescribe preventive medications and monitor blood chemistry closely. If you are in this category and notice changes in your urine color, output, or the onset of flank or abdominal pain, flagging it early can prevent a small crystal deposit from becoming a large obstructing stone.
Patients who have undergone pelvic radiation should be aware that urinary symptoms emerging months or years later could be related to ureteral scarring rather than a new problem. Imaging to check for strictures is a reasonable step when symptoms arise. And for anyone with persistent or recurrent kidney stones, a metabolic workup that includes calcium, uric acid, and parathyroid hormone levels can help identify whether an underlying malignancy is contributing, a connection that is easy to miss if the stones are treated in isolation without investigating why they keep forming.